| Stage | ULS | % of rev | AZZ | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $816M | 100.00% | $487M | 100.00% | ULS ×1.68 |
| Gross profit | $417M | 51.10% | $122M | 25.08% | ULS +26.0pp |
| Operating income | $150M | 18.38% | $84M | 17.21% | ULS +1.2pp |
| Pre-tax income | $338M | 41.42% | $80M | 16.39% | ULS +25.0pp |
| Net income | $254M | 31.13% | $58M | 12.00% | ULS +19.1pp |
| Stage | ULS | AZZ | Gap · A − B |
|---|---|---|---|
| Revenue | $816M100.00% | $487M100.00% | ULS ×1.68 |
| Gross profit | 51.10%$417M | 25.08%$122M | ULS +26.0pp |
| Operating income | 18.38%$150M | 17.21%$84M | ULS +1.2pp |
| Pre-tax income | 41.42%$338M | 16.39%$80M | ULS +25.0pp |
| Net income |
| 31.13%$254M |
| 12.00%$58M |
| ULS +19.1pp |
No disclosed counterparties: AZZ.
None